Filing Details

Accession Number:
0001438588-13-000069
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-12 16:13:48
Reporting Period:
2013-06-11
Filing Date:
2013-06-12
Accepted Time:
2013-06-12 16:13:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 942756657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222790 Phd Md J Patrick Scannon C/O Xoma Corporation
2910 Seventh Street
Berkeley CA 94710
Exec. Vp & Cso Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2013-06-11 10,000 $1.69 27,448 No 4 M Direct
Common Shares Disposition 2013-06-11 10,000 $0.00 17,448 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Incentive Share Option (right to buy) Disposition 2013-06-11 10,000 $0.00 10,000 $1.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,274 2021-10-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 20,339 Indirect by 401(k)
Common Shares 750 Indirect by Daughter
Common Shares 4,053 Indirect by Trust
Footnotes
  1. This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on 3/20/2013.
  2. These shares were disposed of in multiple transactions at prices ranging from $4.00 to $4.08 for aggregate gross proceeds of $40,320.00, of which $16,900.00 was used to pay the option exercise price.
  3. Taken together, the Incentive Stock Option and Non-Qualified Stock Option granted on the same date are exercisable as to 70% of the options on grant date, with the remaining 30% vesting in monthly increments beginning 11/28/2011 and ending 10/28/2013.